Business Wire

Hilton Releases 2020 ESG Report, Reinforcing Commitment to Positive Global Impact

Share

Hilton (NYSE: HLT) has released its 2020 Environmental, Social and Governance (ESG) Report, which highlights the company’s continued commitment to redefining sustainable travel and driving positive impact on people and the planet. Through Hilton’s Travel with Purpose program, the company continues to take important steps to integrate positive social impact and environmental stewardship throughout its operations, communities and supply chain.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210420005911/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Hilton releases 2020 ESG report, reinforcing commitment to positive global impact. (Photo: Business Wire)

“As we weathered this unpredictable year, Hilton has remained focused on our Team Members and the communities we serve around the world,” said Kristin Campbell, general counsel and chief ESG officer, Hilton. “We took a nimble approach during this difficult period to deliver meaningful support, while remaining focused on our bold Travel with Purpose 2030 Goals. Now more than ever, we are committed to our leadership in environmental, social and governance so travelers can enjoy our planet for years to come.”

Hilton’s 2020 ESG Report highlights the company’s environmental and social performance during a tumultuous year. Despite the challenges of 2020, Hilton was proud to receive several significant ESG honors in 2020, including:

  • Named the 2020 Global Industry Leader on the Dow Jones Sustainability Indices, the most prestigious ranking for corporate responsibility and sustainability performance, for the second consecutive year;
  • Recognized just last week as one of the Best Companies to Work For in the U.S. by Great Place to Work and Fortune for the sixth consecutive year, including earning the #1 spot in 2020 and #3 in 2021 – as well as being ranked the #3 World’s Best Workplace and achieving a #1 ranking in seven countries around the world in 2020;
  • Ranked #2 on DiversityInc’s Top 50 Companies for Diversity list; and
  • Named to the 100 Best Corporate Citizens of 2020 list, the only global hotel brand recognized.

An Unprecedented Year for Social Impact

The importance of engaging local communities, supporting Team Members, and promoting a culture of inclusion took on new meaning and urgency in 2020. Hilton took action to support its Team Members and its communities:

  • Partnered with American Express and hotel owners to donate up to one million hotel room nights for U.S. frontline medical professionals leading the fight against COVID-19 and teamed up with World Central Kitchen to provide meals for many of these heroes staying in Hilton’s hotels.
  • Distributed approximately $500,000 to Team Members who contracted the COVID-19 virus to help cover related expenses, including child or elder care.
  • Acted quickly to ensure the safety and wellbeing of Team Members around the world by introducing Hilton CleanStay™,an industry-defining standard of cleanliness and disinfection in collaboration with Reckitt, maker of Lysol and Dettol.
  • Awarded 23 grants through the Hilton Effect Foundation to support organizations helping vulnerable communities recover from COVID-19. In total, the Foundation invested more than $1 million in COVID-19 community response during 2020.
  • Remained committed to doubling the company’s social impact by 2030. Despite the challenges the hospitality industry faced in 2020, Hilton realized many achievements including contributing 185,000 volunteer hours and creating new ways for Team Members to volunteer virtually. Hilton also continued to drive inclusive growth through the company’s award-winning Supplier Diversity Program.
  • Focused on building a diverse, equitable and inclusive workplace for its Team Members and guests. Hilton received a rating of 100% on the Human Rights Campaign’s Corporate Equality index for the seventh year in a row and is committed to achieving global gender parity and 25% U.S. ethnic representation at corporate leadership levels by the end of 2027.
  • Partnered with the NAACP’s Empowerment Program to advance equal rights and awarded grants to nonprofits that are at the front lines of the fight for racial justice, including the NAACP and National Urban League.
  • Launched an internal Courageous Conversation virtual learning series that tackled critical topics including systemic racism, privilege, allyship and women leaving the workplace.
  • Set new industry standards by contributing to the World Travel & Tourism Council’s (WTTC’s) new high-level guidelines for diversity and inclusion in the travel and tourism sector.

Continued Focus on Sustainability

Hilton operates in some of the most beautiful destinations around the world and recognizes its critical responsibility to protect the planet so that it remains healthy and vibrant for future generations. This year, Hilton achieved the following:

  • Remained fully committed to halving its environmental impact and took immediate action to train hotel teams to adopt techniques to conserve resources in times of low occupancy.
  • Took steps to increase sourcing of renewable energy at hotels around the world, in line with the company’s science-based targets. In 2020, the majority of Hilton managed hotels in the U.K. began procuring 100 percent renewable electricity.
  • Undertook a thorough ESG materiality assessment to ensure the company’s Travel with Purpose programs remained aligned with the issues that matter most to Hilton’s business and stakeholders.
  • Continued to enhance Hilton’s award-winning LightStay program, which all of Hilton’s 6,400+ hotels use to measure and manage their environmental and social impact.
  • Established waste reduction standards for the Hilton EventReady with CleanStay meetings and events program.
  • Collaborated with its hotel ownership community to continue to identify innovative and meaningful ways to adapt to the changing needs of its guests, Team Members and communities.

Hilton’s 2020 ESG Report was prepared in accordance with the Global Reporting Initiative (GRI) Standards and integrates the recommendations of the Sustainability Accounting Standards Board (SASB) and the Taskforce on Climate-related Financial Disclosures (TCFD). In addition to the ESG Report and website, Hilton externally reports on its Travel with Purpose strategy, programs and progress towards its 2030 Goals in the company’s Form 10-K, Annual Report and Proxy Statement. For more information about Hilton’s ESG efforts, visit cr.hilton.com.

* Unless otherwise indicated, all hotel data reflects Hilton’s 2020 annual report announcement (April 9). More information can be found on Hilton’s Investor Relations website.

About Hilton

Hilton (NYSE: HLT) is a leading global hospitality company with a portfolio of 18 world-class brands comprising more than 6,400 properties and more than one million rooms, in 119 countries and territories. Dedicated to fulfilling its founding vision to fill the earth with the light and warmth of hospitality, Hilton has welcomed more than 3 billion guests in its more than 100-year history, earned a top spot on the 2020 World’s Best Workplaces list, and was named the 2020 Global Industry Leader on the Dow Jones Sustainability Indices. In 2020, Hilton CleanStay was introduced, bringing an industry-defining standard of cleanliness and disinfection to hotels worldwide. Through the award-winning guest loyalty program Hilton Honors, the more than 112 million members who book directly with Hilton can earn Points for hotel stays and experiences money can’t buy, plus enjoy instant benefits, including contactless check-in with room selection, Digital Key, and Connected Room. Visit newsroom.hilton.com for more information, and connect with Hilton on Facebook, Twitter, LinkedIn, Instagram and YouTube.

About Travel with Purpose

Travel with Purpose is Hilton’s Environmental, Social and Governance (ESG) strategy to redefine and advance sustainable travel globally. By 2030, we plan to double our investment in social impact and cut our environmental footprint by half. We track, analyze and report our environmental and social impact at each of Hilton’s more than 6,400 hotels through LightStay, our award-winning performance management system. Travel with Purpose capitalizes on Hilton’s global scale to catalyze local economic growth; respect human rights; invest in people and local communities; and preserve our planet by reducing our impact on natural resources. Our strategy aligns with the United Nations Sustainable Development Goals. Visit cr.hilton.com to learn more.

About Hilton Effect Foundation

The Hilton Effect Foundation is Hilton’s primary international philanthropic arm. The Foundation is a nonprofit established in the U.S. and is a registered 501(c)3 charitable organization. The Foundation awards grants, in alignment with Hilton’s Travel with Purpose 2030 Goals, that have a positive impact on travel destinations around the world. Foundation grants are awarded throughout the year in accordance with tax and legal requirements. Visit HiltonEffect.org for more information.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Lana Petruzzo
Hilton
+1 703 883 6065
Lana.Petruzzo@Hilton.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

TII Launches Falcon Reasoning: Best 7B AI Model Globally, Also Outperforms Larger Models5.1.2026 15:54:00 EET | Press release

The Technology Innovation Institute (TII), the applied research pillar of Abu Dhabi’s Advanced Technology Research Council (ATRC), has announced the release of Falcon H1R 7B, a next-generation AI model that takes a significant step toward making advanced AI more accessible than ever, by delivering world-class reasoning performance in a compact, efficient, and openly available format. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260105981339/en/ TII Launches Falcon Reasoning: Best 7B AI Model Globally, Also Outperforms Larger Models (Graphic: AETOSWire) With just 7 billion parameters, Falcon H1R 7B challenges and, in many cases, outperforms larger open-source AI models from around the world, including models from Microsoft (Phi 4 Reasoning Plus 14B), Alibaba (Qwen3 32B), and NVIDIA (Nemotron H 47B). This model release reaffirms TII’s position at the forefront of efficient AI innovation and reinforces the UAE’s growing influ

Curing the Incurable with ‘Biological Age Zero’ Cells: Clonell™ Launches the Ultimate Regenerative Medicine Platform5.1.2026 15:00:00 EET | Press release

Clonell Therapeutics, Inc., a leading biotechnology company dedicated to curing intractable and incurable diseases, announced today the official launch of the world's first 'Patient-Specific Embryonic Stem Cell (Somatic Cell Nuclear Transfer-derived Embryonic Stem Cell, hereinafter SCNT-ESC)' therapy platform based on Somatic Cell Nuclear Transfer (SCNT) technology. Concurrently, the company has initiated its innovative 'Patient-Initiated Clinical Trial™' to apply this breakthrough technology directly to patients. This platform launch is evaluated as presenting the true 'Gold Standard' in regenerative medicine by perfectly resolving the inherent challenges—such as immune rejection, incomplete reprogramming, and the inheritance of aging—that have been cited as limitations of existing stem cell therapies. Clonell's SCNT technology establishes a patient-specific embryonic stem cell line by transferring the nucleus of a patient's somatic cell into a healthy enucleated oocyte. This process

Incyte Announces Positive Topline Results from Pivotal Study of Tafasitamab (Monjuvi ® /Minjuvi ® ) as a First-line Treatment for Diffuse Large B-Cell Lymphoma5.1.2026 14:30:00 EET | Press release

Incyte (Nasdaq:INCY) today announced positive topline results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19 targeting monoclonal antibody, and lenalidomide in addition to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone) compared to R-CHOP alone as a first-line treatment for adults with newly diagnosed diffuse large B-cell lymphoma (DLBCL) with an International Prognostic Index (IPI) score of three to five (3-5) for patients >60 years of age, or age-adjusted IPI (aaIPI) of two to three (2-3) for patients ≤60 years of age. The trial met its primary endpoint of progression-free survival (PFS) by investigator assessment (Hazard Ratio 0.75 [0.59,0.96]; p-value 0.019), according to Lugano 2014 criteria. The trial also met its key secondary endpoint of event-free survival (EFS) by investigator assessment. No new safety signals were observed. “The frontMIND stud

HELUS Pharma Propels Therapeutic Innovation in Mental Health and Commences Trading on Nasdaq5.1.2026 14:30:00 EET | Press release

Cybin Inc. (the “Company”) doing business as Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP) (“Helus Pharma”), a clinical stage pharmaceutical company committed to helping minds heal by developing NSAs, today announced that the Company will operate under the business name Helus Pharma (pronounced “Heal-Us”) and trade on Nasdaq with ticker symbol HELP. “Our new business name more accurately describes our compounds and reflects our anticipated transformation from a global clinical stage discovery and development company to a commercial-ready pharmaceutical company, with our two lead candidates HLP003 and HLP004,” said Eric So, interim chief executive officer of the Company. “Over the past several years, we have advanced our pipeline portfolio of differentiated, proprietary NSA drug candidates, which includes over 350 filed patents with more than 100 already granted. We are approaching the commercialization of HLP003 with strong clinical data and significant market potential, subject to the

Takeda and Protagonist Announce Submission of New Drug Application (NDA) for Rusfertide for Treatment of Polycythemia Vera (PV)5.1.2026 14:00:00 EET | Press release

Takeda (TSE:4502/NYSE:TAK) and Protagonist Therapeutics (Nasdaq: PTGX) (“Protagonist”) announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval of rusfertide for the treatment of adults with polycythemia vera (PV). Rusfertide is an investigational first-in-class subcutaneously administered hepcidin mimetic peptide designed to regulate iron homeostasis and red blood cell production to control hematocrit levels in patients with PV. “This is an important milestone toward our goal of addressing critical gaps that patients living with polycythemia vera face today,” said Teresa Bitetti, President, Global Oncology Business Unit, Takeda. “The comprehensive VERIFY study data underscore rusfertide’s strong clinical profile and potential to provide sustained hematocrit control while reducing phlebotomy and symptom burden. Our collaboration with Protagonist exemplifies how partnerships can advance innovative science, with a focus on m

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye